FDA Inspection
Lupin Ltd.Lupin Ltd. – FDA Inspection, Mar 15, 2024
Record Details
This FDA Inspection record concerns Lupin Ltd., with an inspection on March 15, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f4abd996-7c86-43f6-9f28-c214fcdc2bdd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1235550
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Lupin Ltd.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2025 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| February 14, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2019 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| July 28, 2017 | Not classified | Office of Inspections and Investigations | |
| April 26, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Lupin Ltd.
- FDA Inspection 1280668 - 2025-09-05
- FDA Inspection 1121188 - 2020-02-14
- FDA Inspection 1090546 - 2019-05-15
- FDA Inspection 1024531 - 2017-07-28
- FDA Inspection 1012780 - 2017-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.